|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1994-1-13
|
|
pubmed:abstractText |
Patients with chronic coronary artery disease exhibit a dysfunctioning endothelium, which may be responsible for exercise-induced platelet activation and expression of a procoagulant moiety. In this study, we evaluated the therapeutic efficacy of a low molecular weight heparin (Parnaparin) in patients with stable angina pectoris.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
88
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2517-23
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8252662-Adult,
pubmed-meshheading:8252662-Aged,
pubmed-meshheading:8252662-Angina Pectoris,
pubmed-meshheading:8252662-Bleeding Time,
pubmed-meshheading:8252662-Cardiovascular Agents,
pubmed-meshheading:8252662-Double-Blind Method,
pubmed-meshheading:8252662-Drug Therapy, Combination,
pubmed-meshheading:8252662-Exercise Test,
pubmed-meshheading:8252662-Female,
pubmed-meshheading:8252662-Fibrinogen,
pubmed-meshheading:8252662-Heparin, Low-Molecular-Weight,
pubmed-meshheading:8252662-Humans,
pubmed-meshheading:8252662-Male,
pubmed-meshheading:8252662-Middle Aged,
pubmed-meshheading:8252662-Platelet Aggregation
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trial.
|
|
pubmed:affiliation |
Institute of Cardiology, University of Bologna, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
In Vitro,
Randomized Controlled Trial
|
